Current approach to hereditary hemochromatosis;Visão atual da hemocromatose hereditária

Revista Brasileira de Hematologia e Hemoterapia

Volumn 32, Issue 6, 2010, Pages 469-475

  Cançado, Rodolfo Delfini ^a   Chiattone, Carlos Sérgio ^a  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

Author keywords

Hemochromatosis genetics; Hemocromatosis congenital; Iron deficiency metabolism; Iron overload; Phlebotomy

Indexed keywords

EID: 79952343335     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842010000600011     Document Type: Review

References (42)

1. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med. 2004;350(23):2383-9.
2. Andrews NC.Forging a field: the golden age of iron biology. Blood. 2008;112(2):219-30.
3. Fix OK, Kowdley KV. Hereditary hemochromatosis. Minerva Med. 2008;99(6):605-17.
4. Brissot P, de Bels F. Current approaches to the management of hemochromatosis. Hematology Am Soc Hematol Educ Program. 2006:36-41.
5. Pietrangelo A. Inherited metabolic disease of the liver. Curr Opin Gastroenterol. 2009;25(3):209-14.
6. Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelønning K, Fjosne U, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons.Scand J Gastroenterol. 2001;36(10):1108-15.
7. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Hemochromatosis and iron-overloadscreening in a racially diverse population. N Engl J Med. 2005;352(17):1769-78.
8. Agostinho MF, Arruda VR, Basseres DS, Bordin S, Soares MC, Menezes RC, et al. Mutation analysis of the HFE gene in Brazilian populations. Blood Cells Mol Dis. 1999;25(5-6):324-7.
9. Calado RT, Franco RF, Pazin-Filho A, Simões MV, Marin-Neto JA, Zago MA. HFE gene mutations in coronary atherothrombotic disease. Braz J Med Biol Res. 2000;33(3):301-6.
10. Pereira AC, Mota GF, Krieger JE. Hemochromatosis gene variants in three different ethnic populations: effects of admixture for screening programs. Hum Biol. 2001;73(1):145-51.
11. Oliveira TM, Souza FP, Jardim AC, Cordeiro JA, Pinho JR, Sitnik R et al. Mutations in the HFE gene (C282Y, H63D, S65C) in a Brazilian population. Braz J Med Biol Res. 2006;39(12):1575-80.
12. Terada CT, Santos PC, Cançado RD, Rostelato S, Lopreato FR, Chiattone CS, et al. Iron deficiency and frequency of HFE C282Y gene mutation in Brazilian blood donors. Transfus Med. 2009; 19(5):245-51.
13. Bulaj ZJ, Ajioka RS, Phillips JD, LaSalle BA, Jorde LB, Griffen LM, et al. Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med. 2000;343(21):1529-35.
14. Wojcik JP, Speechley MR, Kertesz AE, Chakrabarti S, Adams PC, et al. Natural history of C282Y homozygotes for hemochromatosis. Can J Gastroenterol. 2002;16(5):297-302.
15. Ajioka RS, Kushner JP. Clinical consequences of iron overload in hemochromatosis homozygotes. Blood. 2003;101(9):3351-3; discussion 3354-8.
16. oA (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002;359(9302):211-8.
17. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T, et al Comment in: Lancet. 2002;360(9330):411-2
18. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T, et al author reply 413-4
19. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T, et al Lancet. 2002;360 (9330):412-3
20. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T, et al author reply 413-4
21. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T, et al Lancet. 2002;360(9330):412
22. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T, et al discussion 413-4
23. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T, et al Hepatology 2002;36(2):500-3
24. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T, et al Lancet. 2005;366 (9482):269-71.
25. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008;358(3):221-30.
26. Gurrin LC, Osborne NJ, Constantine CC, McLaren CE, English DR, Gertig DM, et al. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis. Gastroenterology. 2008;135(6):1945-52
27. Gurrin LC, Osborne NJ, Constantine CC, McLaren CE, English DR, Gertig DM, et al.Comment in: Gastroenterology. 2008;135(6):1855-7.
28. Cançado RD, Guglielmi AC, Vergueiro CS, Rolim EG, Figueiredo MS, Chiattone CS, et al. Analysis of HFE gene mutations and HLA-A alleles in Brazilian patients with iron overload. Sao Paulo Med J. 2006;124(2):55-60.
29. Deugnier Y, Brissot P, Loréal O. Iron and the liver: update 2008. J Hepatol. 2008;48 (Suppl 1):S113-23.
30. Beutler E. The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. Blood. 2003;101(9):3347-50.
31. Pietrangelo A, Oude Elferink R, Prieto J, Bacon BR, et al. Genetics in liver diseases. J Hepatol. 2007;46(6):1143-8.
32. Deugnier YM, Loréal O, Turlin B, Guyader D, Jouanolle H, Moirand R, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology. 1992;102(6):2050-9.
33. Brissot P, Troadec MB, Bardou-Jacquet E, Le Lan C, Jouanolle AM, Deugnier Y, et al. Current approach to hemochromatosis. Blood Rev. 2008;22(4):195-210.
34. Waalen J, Felitti VJ, Gelbart T, Beutler E. Screening for hemochromatosis by measuring ferritin levels: a more effective approach. Blood. 2008;111(7):3373-6.
35. Olynyk JK, Gan E, Tan T. Predicting iron overload in hyperferritinemia. Clin Gastroenterol Hepatol. 2009;7(3):359-62.
36. Mariani R, Pelucchi S, Perseghin P, Corengia C, Piperno A, et al. Erytrocytapheresis plus erythropoietin: an alternative therapy for selected patients with hemochromatosis and severe organ damage. Haematologica. 2005;90(5):717-8.
37. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood. 2006; 107(9):3455-62
38. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, et al. Comment in: Blood. 2006;108(2):778
39. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, et al. Blood. 2006;108(2):774-5
40. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, et al. author reply 775-6
41. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, et al. Blood. 2006; 108 (5): 1775-6
42. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, et al. author reply 1776.